BioLife Sciences Market Cap

BioLife Sciences has a market cap or net worth of $4.83 thousand as of May 1, 2025. Its market cap has decreased by -98.89% in one year.

Market Cap

4.83K

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since September 15, 2020, BioLife Sciences's market cap has decreased from 89.39M to 4.83K, a decrease of -99.99%. That is a compound annual growth rate of -88.05%.

Market Cap History

Date	Market Cap	% Change
Apr 30, 2025	4.83K	-
Dec 31, 2024	4.83K	-99.33%
Dec 29, 2023	724.41K	-84.62%
Dec 30, 2022	4.71M	-94.56%
Dec 31, 2021	86.56M	249.03%
Dec 31, 2020	24.80M	-72.26%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.62B
Nika Pharmaceuticals	1.02B
Veradigm	721.11M
Tian'an Technology Group	546.22M
Glass House Brands	513.23M
Elite Pharmaceuticals	441.84M
Northwest Biotherapeutics	424.05M
CytoDyn	316.28M

Market Cap Rankings